【摘要】：目的:檢測(cè)上皮間質(zhì)轉(zhuǎn)化(epithelial-mesenchymal transition,EMT)相關(guān)標(biāo)志物E鈣黏素、波形蛋白在無遠(yuǎn)處轉(zhuǎn)移的結(jié)腸癌組織、伴有肝轉(zhuǎn)移的結(jié)腸癌組織及結(jié)腸癌肝轉(zhuǎn)移組織的表達(dá)情況,同時(shí)分析結(jié)腸癌組織中E鈣黏素表達(dá)在不同臨床病理特征之間表達(dá)差異性,進(jìn)一步探討EMT在結(jié)腸癌轉(zhuǎn)移中的意義。方法:收集2011年1月至2014年12月山西醫(yī)科大學(xué)第一醫(yī)院及山西省腫瘤醫(yī)院收治的未發(fā)生遠(yuǎn)處轉(zhuǎn)移的結(jié)腸癌患者(15例)及結(jié)腸癌伴肝轉(zhuǎn)移且同期行手術(shù)切除患者(20例)的結(jié)腸癌組織、結(jié)腸癌肝轉(zhuǎn)移組織病理蠟塊(石蠟包埋標(biāo)本)。采用免疫組化方法(SP法)檢測(cè)相應(yīng)癌組織的E鈣黏素、波形蛋白的表達(dá)情況。隨機(jī)選擇10個(gè)高倍視野(40×),每個(gè)視野計(jì)數(shù)100個(gè)細(xì)胞,以不表達(dá)或陽性細(xì)胞數(shù)25%判為(-),當(dāng)細(xì)胞染色較強(qiáng)或陽性染細(xì)胞數(shù)75%判為(+),其余陽性細(xì)胞數(shù)25%~75%判為(±),其中(-)、(±)均視為陰性,并測(cè)量組織中蛋白表達(dá)平均灰度值。利用SPSS軟件進(jìn)行數(shù)據(jù)分析,定量資料之間比較采用t檢驗(yàn),計(jì)數(shù)資料之間比較采用χ2檢驗(yàn),均以雙側(cè)檢驗(yàn)P0.05表示差異具有統(tǒng)計(jì)學(xué)意義。結(jié)果:(1)E鈣黏素表達(dá)在無遠(yuǎn)處轉(zhuǎn)移及有遠(yuǎn)處轉(zhuǎn)移的結(jié)腸癌組織表達(dá)陽性率分別為86.7%(13/15)、35.7%(5/14),差異具有統(tǒng)計(jì)學(xué)意義(P0.05);(2)E鈣黏素主要表達(dá)于細(xì)胞膜,在結(jié)腸癌組織及同其期肝轉(zhuǎn)移組織中陽性表達(dá)為分別為25%(5/20)、40%(8/20),平均灰度值為173.075±29.770、175.540±26.5738,差異不具有統(tǒng)計(jì)學(xué)意義(P0.05);波形蛋白在結(jié)腸癌組織、結(jié)腸癌肝轉(zhuǎn)移組織中間質(zhì)細(xì)胞表達(dá)明顯,并偶見腫瘤細(xì)胞胞漿表達(dá),在兩組內(nèi)陽性表達(dá)率分別為80%(16/20)、65%(13/20),平均灰度值分別為110.079±22.434、100.187±13.891,差異不具有統(tǒng)計(jì)學(xué)意義(P0.05);(3)E鈣黏素在結(jié)腸癌組織表達(dá)與性別、年齡、腫瘤大小、分化程度、浸潤(rùn)深度等臨床病理特征之間表達(dá)差異不具有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:(1)E鈣黏素在未發(fā)生遠(yuǎn)處轉(zhuǎn)移和已發(fā)生遠(yuǎn)處轉(zhuǎn)移結(jié)腸癌組織中的表達(dá)差異對(duì)評(píng)估結(jié)腸癌轉(zhuǎn)移風(fēng)險(xiǎn)可能具有重要的參考價(jià)值。(2)EMT標(biāo)志物(E鈣黏素、波形蛋白)在結(jié)腸癌組織及同期肝轉(zhuǎn)移組織中表達(dá)水平相似,提示早期結(jié)腸癌細(xì)胞發(fā)生上皮間質(zhì)轉(zhuǎn)化,有利于腫瘤的發(fā)生發(fā)展,當(dāng)腫瘤轉(zhuǎn)移至新的部位,可能又發(fā)生間質(zhì)上皮轉(zhuǎn)化,有利于腫瘤在新的環(huán)境(如肝臟)中生長(zhǎng)。(3)腫瘤組織的異質(zhì)性造成不同區(qū)域組織生物學(xué)特性的不完全一致可能是分子標(biāo)記物表達(dá)不均勻的原因。
[Abstract]:Objective: to detect the expression of E-cadherin and vimentin in colon cancer tissues without distant metastasis, colon cancer tissues with liver metastasis and colon cancer liver metastases. At the same time, we analyzed the difference of E-cadherin expression among different clinicopathological features in colon cancer tissues, and further discussed the significance of EMT in colon cancer metastasis. Methods: from January 2011 to December 2014, 15 patients with colon cancer without distant metastasis and 15 patients with colon cancer accompanied with liver metastasis who were admitted to the first Hospital of Shanxi Medical University and Shanxi Cancer Hospital were collected. (20 cases) of colon cancer, Pathological wax masses (paraffin embedded specimens) of liver metastases from colon cancer. The expression of E-cadherin and vimentin was detected by immunohistochemical method (SP). Ten high-power visual fields (40 脳) were randomly selected. 100 cells were counted in each field, and 25% of the cells without expression or positive were judged as (-), and 75% of the cells with strong staining or positive staining were judged as (),. 75% of the other positive cells were found to be (鹵), of which (-), (鹵) were considered negative, and the average gray value of protein expression was measured. The data were analyzed by SPSS software. T test was used to compare the quantitative data and 蠂 2 test was used to compare the count data. Results: (1) the positive rates of E-cadherin expression were 86.7% (13 / 15) and 35.7% (5 / 14) in colon cancer tissues with no distant metastasis and distant metastasis respectively (P0.05). (2) E-cadherin was mainly expressed on cell membrane. The positive expression of E-cadherin was 25% (5 / 20) and 40% (8 / 20) in colon cancer and liver metastasis respectively, and the average gray value was 173.075 鹵29.770175.540 鹵26.5738. The difference was not statistically significant (P0.05). The expression of vimentin in the stromal cells of colon cancer and liver metastases was obvious, and the expression of vimentin in the cytoplasm of tumor cells was occasionally observed. The positive expression rates of vimentin in the two groups were 80% (16 / 20) and 65% (13 / 20), respectively. The average gray value was 110.079 鹵22.434100.187 鹵13.891respectively, the difference was not statistically significant (P0.05). (3) there was no significant difference between the expression of E-cadherin and clinicopathological features such as sex, age, tumor size, differentiation, depth of invasion and so on (P0.05). Conclusion: (1) the difference of E-cadherin expression in colorectal cancer tissues without or without distant metastasis may be of important value in assessing the risk of colon cancer metastasis. (2) the EMT marker (E-cadherin) may be useful in evaluating the risk of colon cancer metastasis. The expression level of vimentin in colon cancer tissues and liver metastasis tissues is similar, suggesting that the epithelial interstitial transformation of colon cancer cells occurs in the early stage, which is beneficial to the development of tumor, and when the tumor metastases to a new site, the expression of vimentin is similar. Another transition of the interstitial epithelium may occur. (3) the heterogeneity of tumor tissues may cause the heterogeneity of tissue biological characteristics in different regions, which may be the reason for the uneven expression of molecular markers.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R735.35

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王毅;王芳;趙宏宇;王陽;周余來;原田守;山田亮;伊東恭悟;;前列腺酸性磷酸酶——結(jié)腸癌主動(dòng)免疫治療新靶點(diǎn)[J];中國(guó)老年學(xué)雜志;2008年18期

2 邵世和,謝立蘋,霍龍;硒與結(jié)腸癌研究進(jìn)展[J];北華大學(xué)學(xué)報(bào)(自然科學(xué)版);2003年05期

3 程文芳,顧曉紅,錢偉,易粹瓊;結(jié)腸癌中腫瘤壞死因子相關(guān)凋亡誘導(dǎo)配體受體的表達(dá)[J];胃腸病學(xué);2003年02期

4 郭艷麗,閆慧明,宋善俊;組織因子在結(jié)腸癌表達(dá)的臨床意義(英文)[J];中國(guó)現(xiàn)代醫(yī)學(xué)雜志;2005年15期

5 李建國(guó);王雙燕;沈若武;王守彪;;血管內(nèi)皮生長(zhǎng)因子與結(jié)腸癌的相關(guān)性研究[J];山東醫(yī)藥;2006年07期

6 孫軍;沈磊;羅和生;沈志祥;;結(jié)腸癌瘦素和瘦素受體表達(dá)及其意義[J];中華消化雜志;2006年08期

7 宋e，

本文編號(hào)：2421836